RECURRENT POLYSINUSITIS AS LEADING CLINICAL EVIDENCE OF CYSTIC FIBROSIS. SUCCESSFUL ENDONASAL APPLICATION OF DORNASE ALFA
.
Saved in:
Main Authors: | I.K. Asherova, V.V. Tarakanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Union of pediatricians of Russia
2009-10-01
|
Series: | Педиатрическая фармакология |
Online Access: | https://www.pedpharma.ru/jour/article/view/975 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PECULIARITIES OF DORNASE ALFA AND KINESITHERAPY USE IN CHILDREN WITH CYSTIC FIBROSIS
by: O. I. Simonova
Published: (2013-07-01) -
AN IMPORTANT COMPONENT OF BASIC THERAPY IN CYSTIC FIBROSIS (MUCOVYSCIDOSIS) IN CHILDREN: DORNASE ALFA
by: O.I. Simonova
Published: (2011-10-01) -
A MUCOLYTIC WITH ANTIINFLAMMATORY QUALITIES FOR CHILDREN SUFFERED FROM CYSTIC FIBROSIS: DORNASE ALFA
by: O. I. Simonova, et al.
Published: (2012-12-01) -
SPECIFIC DISORDERS OF THE RESPIRATORY SYSTEM IN CYSTIC FIBROSIS. CLINICAL EFFICACY OF THERAPY WITH DORNASE ALFA IN CHILDREN
by: T.V. Simanova, et al.
Published: (2010-11-01) -
DORNASE ALFA IN RUSSIA: 15 YEARS LATER. EFFICACY OF THE DRUG IN THE BASIC TREATMENT IN CHILDREN WITH CYSTIC FIBROSIS
by: O. I. Simonova, et al.
Published: (2012-03-01)